Cash Magazine



In addition to Geneva-based Xcelens two other Medtech companies got the CTI Label. They also have already something to show:



For the development of bio-technological drugs it is important to understand, how proteins work in the human cels. Up to now with conventional mass spectrometers only single proteins could be analyzed, although proteins are only effective in combination with other proteins. Zurich-based CovalX developed an overall solution for the analysis of protein complexes. It consists of a chemical solution, a mass detector amending conventional mass detectors, and the software for the analysis. Both CovalX founders Alexis Nazabal and Ryan Wenzel came to Switzerland to pursue their scientific careers. “But when we realized that our solution is unique, we did not hesitate to change into business” Nazabal says.